Patent ID: 7517886
Filing Date: 2009-04-14
Classification: A61K,A61P,C07D,Y10S

Abstract:
1. A method of treating an autoimmune disease and/or one or more symptoms associated therewith, comprising the step of administering to a subject suffering from an autoimmune disease an effective amount of a 2,4-pyrimidinediamine compound according to structural formula (I): or a salt, hydrate, solvate and/or N-oxides thereof, wherein: the autoimmune disease is selected from the group consisting of Hashimoto's thyroiditis, autoimmune hemolytic anemia, autoimmune atrophic gastritis of pernicious anemia, autoimmune encephalomyelitis, autoimmune orchitis, Goodpasture's disease, autoimmune thrombocytopenia, sympathetic opthalmia, myasthenia gravis, Graves' disease, primary biliary cirrhosis, chronic aggressive hepatitis, membranous glomerulopathy and an autoimmune disease involving a systemic autoimmune disorder; wherein one or both of R wherein